Replies to post #254804 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

I didn't see that one on the Kevetrin fact sheet.

Kevetrin Fact Sheet

1. Demonstrated P53 modulation in a preclinical settings.
2. Demonstrated improved results as a combo treatment in preclinical settings.
3. Proven safe at tested doses in a phase 1 clinical trial.
4. Showed p53 modulation in 2/2 patients in a phase 2 clinical trial.
5. Preclinical studies suggest bioavailability will be high enough to be effective when delivered orally.